INCIVO® (Telaprevir) Demonstrates Efficacy And Increased Cure Rates Among Cirrhotic Patients With Genotype-1 Chronic HCV Compared To Standard Of Care
SAN FRANCISCO, November 5, 2011 /PRNewswire/ --
Data presented at AASLD 2011 highlights efficacy in typically hard to treat patients
NOT INTENDED FOR US JOURNALISTS
Janssen Pharmaceutica NV (…